Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 74 Carcinoma, Intraductal, Noninfiltrating 11 Breast Carcinoma In Situ 9 Breast Neoplasms, Male 8 Carcinoma, Ductal, Breast 5 Inflammatory Breast Neoplasms 4 Depression 3 Carcinoma, Lobular 3 Triple Negative Breast Neoplasms 2 Radiation Injuries 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Skin Abnormalities 1 Recurrence 1 Pain 1 Paget's Disease, Mammary 1 Neoplasm Metastasis 1 Melanoma 1 Malnutrition 1 Infertility 1 Hot Flashes 1 HER2 Negative Breast Cancer 1 Fatigue 1 Endometrial Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Cardiotoxicity 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × Breast × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡